News

August 12, 2026
Generated Q2 2026 net revenue of $126.1 million and Adjusted EBITDA¹ of $29.1 million Scaled retail footprint to 55 locations, up from 48 at the end of Q1 2026² Grew market share by ~5% across our seven markets, retail transactions up ~7% sequentially³ Filed definitive proxy statement for reverse
May 13, 2026
Generated Q1 2026 net revenue of $116.9 million and Adjusted EBITDA 1 of $26.3 million 51-location footprint to date, with five dispensaries added in 2026 2 Ranked No. 2 brand house in Illinois, Massachusetts, and New Jersey combined in Q1 2026 3 Rescheduling poised to unlock immediate and
March 12, 2026
Delivered Q4 2025 and FY 2025 revenue of $120.5 million and $500.6 million Expanded Adjusted EBITDA Margin 1  to 25.1% in Q4 2025 and 23.4% for FY 2025 Maintained strong liquidity with $ 85.7 million in cash and no significant near-term debt Retail footprint reaches 48 locations as densification